The aim of this study was to investigate the effects and the underlying mechanisms of fentanyl anaesthetic on T lymphocytes isolated from human umbilical cord blood in vitro. The percentages of CD4 + , CD8 + and regulatory T (Treg) cells in human umbilical cord blood mononuclear cells (UBMC) treated with fentanyl in vitro were analysed by flow cytometry. The levels of cytokines IFN-c, IL-2, IL-4 and IL-17 secreted by activated CD4 + T cells were measured by ELISA assays. Expressions of MAPK and NF-jB signalling pathway proteins were determined by Western blotting. Effects of fentanyl on IKK and p65 expression promoter activities were analysed by luciferase assay. Fentanyl decreased the percentages and amounts of CD4 + , CD8 + and Foxp3 + Treg T lymphocyte subsets in UBMCs in a dose-dependent manner. Fentanyl inhibited the proliferation and induced apoptosis of activated CD4 + T cells dose dependently. Fentanyl could not reverse the increase of cell proliferation in activated groups to be equivalent with those in inactivated group. Secretions of IFN-c, IL-2 and IL-4 cytokines were significantly decreased by moderate to high dose of fentanyl compared with controls. No significant differences were observed in protein expressions of MAPK pathway. In addition, fentanyl suppressed the IKKs-mediated activation of NF-jB. This study demonstrates that fentanyl exerts immunosuppressive effects on T lymphocytes obtained from UBMCs. Thus, the clinical application of fentanyl would not only relieve pain caused by surgery but regulate immune responses post-operation possibly through inhibition of IKKs-mediated NF-jB activation.
Introduction
The parturition results in tissue injury and triggers inflammation; thus, immune systems play important parts in parturition and post-partum recovery [1] . In the past two decades, opiate anaesthetics have been reported to exert different regulations on immune systems [2] [3] [4] [5] and contribute to the development of post-injury immunosuppression [6] . The hypothesis is that opiate anaesthetics might conduct immunoregulatory functions in tissue recovery and inflammation modulation in parturition and post-partum terms.
Fentanyl, a kind of synthetic opioid, has been widely used for anaesthesia and analgesia. It has been demonstrated to reduce inflammatory responses in septic mice [7] , decreased regulatory T cells (Tregs) number in vitro [8] and inhibit the expression of proinflammatory cytokines, including IL-6, IL-10 and tumour necrosis factor (TNF)-a, in lipopolysaccharide (LPS)-induced inflammation [9] . Little is known about the effects of fentanyl on immune responses in the immune recovery during the process of labour and post-partum.
In this study, CD4 + T cells were isolated from human umbilical cord blood (hUCB) and treated by fentanyl of different doses to investigate the roles of fentanyl in T lymphocytes and reveal the potential mechanisms in vitro. The aim was to provide a theoretical basis for the clinical application of this analgesic and sedative medication.
Materials and methods
Drug treatment. Fentanyl citrate injection (0.05 mg/ml) was purchased from Yichang Human well Pharmaceutical CO., Ltd, Hubei, China. The concentrations of fentanyl used in this study were referred to those described in previous studies [10, 11] . For phenotype, proliferation, apoptosis, cytokine secretion and luciferase assays, 0, 0.8, 4, 20 ng/ml of fentanyl was added to the corresponding group, respectively. For signalling pathway activation experiment, 4 ng/ml of fentanyl was added to the cultured T cells. Fentanyl was incubated for 7 days in apoptosis assay and 2 h in the other experiments.
Antibodies. The following primary antibodies were used in this study. Antibodies against ERK, p-ERK, p38, p-p38, JNK and p-JNK were purchased from Cell Signaling Technology (Beverly, MA, USA). Rabbit monoclonal antibodies against IKKa, p-IKKa, IKBa, p-IKBa, beta actin, Lamin B1 were purchased from Abcam (Cambridge, MA, USA). Rabbit monoclonal antibody against p65 was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). The horseradish peroxidase-conjugated secondary antibodies were purchased from Bio-Rad laboratories (Hercules, CA, USA).
Grouping. The isolated CD4 + T cells were randomly classified into five groups with corresponding additives as follows: group NT, with no fentanyl, no IL-2 and no anti-CD3/28; group 0, with phosphate-buffered saline (PBS), IL-2 and anti-CD3/28; group 0.8, with 0.8 ng/ml fentanyl, IL-2 and anti-CD3/28; group 4, with 4 ng/ml fentanyl, IL-2 and anti-CD3/28; and group 20, with 20 ng/ml fentanyl, IL-2 and anti-CD3/28.
Collection and processing of hUCB. The collection of human umbilical cord blood (hUCB) was approved by The Fourth Hospital of Shijiazhuang. Informed consents were obtained from three donors before delivery. Before the expulsion of the placenta, the hUCB units were collected in a vacutainer tubes containing preservative-free heparin anticoagulant and were stored and transported at 4°C. No complications were encountered upon hUCB collection, and none of the samples had signs of coagulation or haemolysis. Umbilical blood mononuclear cells (UBMCs) were obtained by density gradient separation using lymphocyte separation medium (Cellgro, Mediatech Inc., Kansas City, MI, USA) and then washed and resuspended in RPMI 1640 (Gibco, Carlsbad, CA, USA) medium containing 10% foetal calf serum plus 2 mM l-glutamine, 10 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulphonic acid (HEPES), pH 7.25, 100 U/ml penicillin and 100 lg/ml streptomycin.
Enrichment, activation and culture of CD4 + T cells. An aliquot of UBMCs was mixed with Dynabeads â untouched TM Human CD4 T cells (Invitrogen, Carlsbad, CA, USA) according to manufacturer's instructions. Enriched CD4 + T lymphocytes were isolated by negative selection using a magnet to remove non-CD4 + T cells. Isolated CD4 + T cells were activated by plated-bound anti-CD3 (OKT3 clone, 0.5 lg/ml; Biolegend, San Diego, CA) and soluble anti-CD28 (CD28.2 clone, 1 lg/ml, Biolegend) monoclonal antibodies (mAbs).
Phenotype analysis of T lymphocytes. Phenotype analysis was performed after hUCB samples were treated by fentanyl of indicated doses for 2 h. Briefly 100 ll of whole hUCB was simultaneously stained with 1 ll of the APC-CD4, PE-CD8 and FITC-Foxp3 monoclonal antibodies (BD Biosciences, Franklin Lakes, NJ, USA), followed by a 30-minute incubation at 4°C in the dark. After the red blood cells were lysed (Lysing Solution, Ortho Diagnostic) and washed twice by centrifugation in PBS containing 0.1% sodium azide and 0.5% bovine serum albumin, the samples were processed by FACS can flow cytometer (Becton Dickinson, Franklin Lakes, NJ) and analysed with Flow Jo software (Treestar, Ashland, OR, USA).
Proliferation assay. Purified CD4 + T cells were isolated from UBMCs according to the manufacturer's instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). CD4 + T cells were labelled with 5 lM carboxyfluorescein succinimidyl ester (CFSE; Invitrogen) in PBS at 37°C. Ten minutes later, an excess of ice-cold RPMI 1640 with 10% FBS was added to the cells to stop the reaction. Then, CFSE-labelled CD4 + T cells (1 9 10 6 /well) were activated anti-CD3 and anti-CD28mAbs, paralleling with the treatment of fentanyl of indicated doses for 7 days. CD4 + T cell proliferation was determined through FACS analysis of CFSE fluorescence intensity.
Cell apoptosis assay. One million isolated CD4 + T cells were seeded to each well in the 24-well plates in RPMI-1640 supplemented with 100 U/ml penicillin, 100 lg/ml streptomycin, 0 or 100 U/ml IL-2 (Peprotech, Rocky Hill, CT, USA), with or without anti-CD3/28 mAb, in the presence or absence of fentanyl of different doses at 37°C in a humidified 5% CO 2 atmosphere for 7 days. To detect apoptotic cells, cultured CD4 + T cells were labelled with fluorescein isothiocyanate (FITC) and propidium iodide (PI) using Annexin V-FITC Apoptosis Detection Kit I (Univ-bio, Shanghai, China) according to the instructions. After trypsin (Gibco, Grand Island, NY, USA) digestion and three ice-cold PBS washes, cells were resuspended in 300 ll of 19 Binding Buffer containing 10 mM HEPES, 140 mM NaCl and 2.5 mM CaCl 2 and stained with 5 ll Annexin V-FITC. After incubated for 15 min in dark at room temperature, 5 ll PI and 200 ll 19 Binding Buffer were added to the cells, followed by an immediate detection using BD FACSCanto II flow cytometry (BD Biosciences, San Jose, CA, USA).
Enzyme-linked immunosorbent assay (ELISA). The IFN-c, IL-2, IL-4 and IL-17 concentrations in the supernatants were determined by corresponding human ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. BCA quantifying the total protein was conducted before ELISA to ensure the same protein quantity was loaded from different culture conditions. The optical density was determined directly using a microplate reader (SpectraMax 190; Molecular Devices, Sunnyvale, CA, USA) at a wavelength of 450 and 550 nm. The 450 nm values were subtracted from the 570-nm values for correction of the optical imperfections. The detection limit was 20 pg/ml.
Western blot analysis. Isolated CD4 + T cells were first treated by 4 ng/ml fentanyl for 2 h and then activated with anti-CD3 for different times, 0, 5, 15, 30 min. Then, cells were lysed in 0.2 ml RIPA buffer containing protease inhibitor cocktail (Sigma, St. Louis, MO, USA) and 25 mM NaF as phosphatase inhibitor. Protein concentration in the RIPA-soluble fractions was determined by a BCA Protein Assay kit (Beyotime Institute of Biotechnology, Shanghai, China). Cell protein samples of 20 lg were separated by 10% SDS-PAGE and transferred to PVDF membranes (Bio-Rad, Hercules, CA, USA). Membranes were incubated in primary antibodies overnight at 4°C after a 2-h block in 5% skim milk at room temperature, followed by incubation in secondary antibodies for 2 h. Then, the signals were visualized using ECL plus Western Blotting Substrate (Thermo Scientific, Waltham, MA, USA) and photographed. Actin and Lamin B were used as the internal references.
Luciferase assay. The HEK293 cells (2 9 10 5 ) were seeded in 24-well plates and transfected with IL-2 promoter reporter plasmid and p65 or IKKb expression plasmids by standard calcium phosphate precipitation. Empty control plasmid was added to ensure that each transfection received the same amount of total DNA. To normalize for transfection efficiency, 1 lg of pRL-TK promoter Renilla luciferase reporter plasmid was added with IL-2 promoter in each transfection. Luciferase assays were performed with a dual-specific luciferase assay kit (Promega, Madison, WI, USA). Firefly luciferase activities were normalized based on Renilla luciferase activities. After 34 h of transfection, cells were incubated with fentanyl of 0.8, 4, 20 ng/ml for 2 h, respectively. Then, cells were harvested for luciferase assays.
Statistical analysis. All experiments were repeated at least three times. Data were analysed using IBMSPSS Statistics 19.0 software (SPSS, Inc., Chicago, IL, USA). Student's t-test or one-way analysis of variance was used to assess differences among the groups. The data are presented as the mean AE standard deviation. P < 0.05 was considered to be statistically significant.
Results

Fentanyl decreased percentages and counts of T lymphocyte subsets obtained from UBMCs in vitro
To document our hypothesis that fentanyl might influence immune responses in and after parturition, the percentages of CD4 + , CD8 + and Foxp3 + Tregs in UBMCs treated by indicated doses of fentanyl were tested by flow cytometry. As shown in Table 1 , the percentages and absolute counts of three T lymphocyte subsets were significantly decreased by fentanyl in a dose-dependent manner, respectively, suggesting that fentanyl might suppress the survival of inflammation-related T cells.
Fentanyl suppressed proliferation and induced apoptosis of CD4 + T cells CD4 + T cells were purified to assess the in vitro impacts of fentanyl on cell proliferation and apoptosis of T lymphocytes. As shown in Fig. 1A , fentanyl inhibited the proliferation of activated CD4 + T cells dose dependently, with significant reductions in the percentages of cells that divided in culture. We also found that fentanyl could not reverse the increase in activated cell proliferation to the level of inactivated cells. In addition, treatment with fentanyl resulted in apoptosis-induced cell death in the activated CD4 + T cells in a dose-dependent manner as measured by flow cytometry (Fig. 1B) , indicating that fentanyl might possess a pro-apoptotic activity on T cells.
Fentanyl influenced the expressions of cytokines secreted by activated CD4
+ T cells
The proliferation of T cells could regulate the intensity of inflammation, and cytokines secreted by them are critical functional factors during the progress of inflammation. The common inflammatory cytokines secreted by T cells are determined by ELISA. Results showed that the secretion of three cytokines in four, IFN-c, IL-2, and IL-4 was decreased significantly in activated CD4 + T cells treated by fentanyl of doses equal or >4 ng/ml (Fig. 2) . Then, the concentration of 4 ng/ml was applied in the following experiments. No statistical significance was observed in IL-17 secretion of activated CD4 + T cells treated by all doses of fentanyl. These results indicated that higher doses of fentanyl could modulate the cytokine section of T lymphocytes.
Fentanyl inhibited the IKKs-mediated activation of NF-jB in activated CD4
To clarify the inhibitory mechanism of fentanyl on proliferation and cytokine section on T lymphocytes, activities of two inflammation-related pathways mediated by T cells, NF-jB and MAPK were determined. After treatment with 4 ng/ml fentanyl for 2 h, isolated CD4 + T cells were activated by anti-CD3 mAb for 0, 5, 15 and 30 min, respectively. Western blotting analysis showed that 5 min after anti-CD3 activation, the expression of p-IKK was significantly decreased in fentanyl-treated groups compared with that in vehicle group, suggesting that fentanyl treatment suppressed the activation of NF-jB by downregulating the expression of the p-IKKa in isolated CD4 + T cells (Fig. 3B) . No significant differences were observed in protein expressions of MAPK pathway (Fig. 3A) . Luciferase assay indicated that fentanyl suppressed the activity of IKKs without affecting that of its downstream substrate p65 (Fig. 3C ).
Discussion
Opioid agent fentanyl is one of the most commonly clinically used analgesic and sedative drugs. In recent years, the immunomodulatory effects of opioids were presented in many tissues and diseases, including surgery [5, 12] , cancer [13] [14] [15] and infections [7, 16, 17] . However, little is known about the effects of fentanyl on immune responses in parturition and post-partum. Human umbilical cord blood (hUCB) collected immediately after delivery has been shown to contain multipotent hematopoietic progenitor cells at a higher frequency and can generate specific phenotypes of T lymphocytes after activation with specific monoclonal antibodies [18] . Nowadays hUCB has been widely used for immunologic investigations including developmental perturbations by antenatal exposures [19, 20] . In this study, we investigated the effects of fentanyl on phenotype, proliferation, apoptosis, cytokine secretion of T cells and the underlying mechanisms of these effects were explored primarily in vitro. To the best of our knowledge, this is the first study to report the suppressive effects of fentanyl on T lymphocytes using hUCB in vitro. CD4 + T cells being activated and differentiated into distinct effect or subtypes play a major role in mediating immune response through the secretion of specific cytokines [21] . Treg plays important role in the maintenance of immunologic tolerance to self and foreign antigen [22] . We determined the percentages of CD4 + , CD8
+ and Foxp3 + regulatory T cells in UBMCs treated by indicated doses of fentanyl by flow cytometry. The results showed that fentanyl dose dependently decreased percentages and amounts of T lymphocyte subsets obtained from UBMCs in vitro (Table 1) . As there were significant reductions in absolute number in these three T lymphocyte subsets, it is possible that these suppressive effects on T subpopulations might be associated with the direct impacts of fentanyl to the survival of T lymphocytes.
Taking into account that fentanyl significantly decreased the absolute numbers of three T subtypes, we speculated that fentanyl might exert this effect through affecting proliferation and/or apoptosis of T lymphocytes. To document the hypothesis, proliferation and apoptosis assay specific for isolated CD4 + T cells treated with fentanyl in vitro were performed. Results of proliferation assay showed that fentanyl inhibited the proliferation of activated CD4 + T cells dose dependently, suggesting that fentanyl might affect the survival of T cells from the aspect of proliferation suppression (Fig. 1A) . We also found that the highest dose (20 ng/ml) of fentanyl could not reverse the increase in proliferation in activated cells to the level of that in inactivated cells, suggesting that higher doses of ............................................................................................................................................................... fentanyl should be applied and tested in future study to improve this result. Moreover, Annexin V/PI doublestaining assay indicated that treatment with fentanyl triggered cell apoptosis in a dose-dependent manner too (Fig. 1B) , indicating that fentanyl might possess a proapoptotic activity to suppress the survival of T lymphocytes. These findings are consistent with previous studies that opioids suppressed T lymphocyte proliferation in autoimmune diseases [23] , induced lymph node lymphocyte apoptosis [24] and altered the balance of intracellular apoptotic and anti-apoptotic elements in acquired immunodeficiency syndrome [25] .
The proliferation of T lymphocytes could regulate the intensity of inflammation and cytokines secreted by them are critical to the pathogenesis of inflammation [26] . Proinflammatory cytokines including IFN-c, IL-2, IL-4 and IL-17 are elevated in infectious diseases [27, 28] and associated with progressive tissue injuries [27] . The proinflammatory cytokines secreted by T cells were determined by ELISA. Results showed that the secretion of three cytokines, IFN-c, IL-2 and IL-4, was decreased significantly in activated CD4 + T cells treated by higher doses fentanyl (Fig. 2) . No statistical significance was observed in IL-17 secreted by activated CD4 + T cells treated with all doses of fentanyl. The reduction in cytokines secretion of T lymphocytes triggered by fentanyl in this study supports the findings reported previously that opioidergic compounds potentially exert protective effect on nervous tissues through immune suppression [29] .
NF-jB and MAPK, inflammation-related pathways mediated by T cells, are reported to be associated with cell proliferation, differentiation and apoptosis [30] [31] [32] . To clarify the inhibitory mechanism of fentanyl on proliferation and cytokine section on T lymphocytes, activities of NF-jB and MAPK were determined. After treatment with 4 ng/ml fentanyl for 2 h, isolated CD4 + T cells were activated by anti-CD3 mAb. Western blotting analysis showed that fentanyl inhibited the activation of NF-jB by downregulating the IKKa phosphorylation after activated by anti-CD3 mAb, without affecting the activation of MAPK pathway (Fig. 3A  and B) . The reporter assay confirmed that fentanyl decreased the activity of IKKs without affecting the activity of its downstream target p65 (Fig. 3C) . These results indicated that fentanyl might suppress survival of CD4 + T lymphocytes through downregulating the IKKsmediated activation of NF-jB. While rescue experiments needed to be performed in future to authenticate this finding.
Conclusions
This study demonstrates that fentanyl exerts immunosuppression in T lymphocytes obtained from UBMCs via affecting phenotypes, inhibiting cell proliferation, inducing apoptosis-related cell death as well as decreasing proinflammatory cytokines secretion, with inhibiting the IKKs-mediated activation of NF-jB as the possible underling mechanism. Thus, the clinical application of fentanyl would not only relieve pain caused by surgery but regulate immune responses postoperation.
